- Offered for Year: 2016/17
- Module Leader(s): Mr Steve Williamson
- Lecturer: Dr Charles Kelly
- Owning School: FMS Graduate School
- Teaching Location: Off Campus
|Semester 2 Credit Value:||20|
This module looks at how new cancer medicines are developed, marketed and introduced into clinical practice. The module includes practical examination of how healthcare providers assess the value and affordability of new cancer medicines. The wider context of the impact new concepts in personalised health care and new medicine technologies will be evaluated.
Outline Of Syllabus
•Product Development -Challenges, Barriers and Benefits.
•Phase I/II/III/IV trials are they still relevant?
•Biomarkers and clinical decision making
•How real decisions are made
•Cancer Drug Fund and the UK approach to commissioning new cancer medicines
•HTA Applications Exercise: Formative Assessment (topic 7)
•Value Based Pricing
•Affordability, what next?
•Marketing and Promotion – does it make a difference to prescribers
•Models of Joint Working between industry and healthcare systems.
|Guided Independent Study||Assessment preparation and completion||3||10:00||30:00|
|Guided Independent Study||Directed research and reading||12||5:00||60:00||Online content|
|Guided Independent Study||Skills practice||1||2:00||2:00||Software|
|Guided Independent Study||Reflective learning activity||12||3:00||36:00||eJournal|
|Guided Independent Study||Independent study||12||3:00||36:00||Supplemental reading|
|Guided Independent Study||Online Discussion||12||3:00||36:00||Via discussion board|
Teaching Rationale And Relationship
Through a series of online tutorials and weekly activities as well as private study (including directed reading) students will gain a detailed knowledge of understanding of how cancer medicines reach patients in the ‘real world’ and gain and insight to the challenges faced by health systems and clinical and financial decision making. Students are encouraged to participate in online collaborative discussions via the discussion boards so they can help debate current practices and the reflective journal will help to consolidate their understanding of the curriculum.
The format of resits will be determined by the Board of Examiners
|Written exercise||2||M||40||Powerpoint presentation slides with teaching notes. Max 10 slides, max 15minute presentation. Notes- max 1000 words|
|Essay||2||M||50||Short essay questions (max 2000 words)|
|Portfolio||2||M||10||Participation in collaborative e-learning activities throughout the module.|
Assessment Rationale And Relationship
This assessment strategy is designed to allow the students' to demonstrate a depth of knowledge in a focused topic of a non-prescriptive aspect of cancer management. It allows assessment of students ability to critically analyse and present to an audience of peers a focused critiqued piece of work.
The short essay questions are designed to assess the students' knowledge and understanding across the breadth of all topics covered in the module.
A participation grade is included to reflect the student's engagement with the collaborative activities included throughout this e-learning module.
- Reading List Website : rlo.ncl.ac.uk